Clinical Trial Update: Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of interferon and octreotide for Zollinger-Ellison syndrome and advanced non-B islet cell cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Cell Adenoma
• Zollinger-ellison Syndrome

Drugs mentioned

• Interferon (interferon)
• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Islet Cell Adenoma, Zollinger Ellison Syndrome | Phase 2 | Status: COMPLETED